Laparoscopic Mini Gastric Bypass Surgery For Morbid Obesity
RamyFouad Hafez;
Abstract
Because obesity is a major global health issue, and conservative or medical treatment is insufficient, antiobesity surgery is rapidly becoming one of the most common surgical procedures performed in gastrointestinal surgery. Surgery has proved its efficiency in treating many of the complications of obesity, such as diabetes, hypertension, hyperlipidemia, sleep apnea syndrome, psychosocial effects, fertility problems, and even cancer-related deaths.The benefits of surgery must be measured against the risks of the procedures.
The field of bariatric surgery has become a very popular and competitive area of medicine, as the incidence of morbid obesity continues to rise and bariatric surgeons respond to the demand for effective treatments. While many doctors prefer to perform the bariatric procedures that have lasted through years of medical scrutiny, other doctors are developing alternatives. One such development is the mini-gastric bypass (MGB), a variation of gastric bypass surgery, which was developed in 1997 by Dr. Robert Rutledge. The mini-gastric bypass reverts back to the simpler loop reconstruction of earlier gastric bypass procedures, but with some improvements. The mini-gastric bypass surgery involves creating a long narrow gastric pouch and connecting new stomach to the side of the small intestine, bypassing 200 cm.
The laparoscopic mini-gastric bypass (LMGB), first reported by Rutledge, is a procedure which uses a divided vertical tube gastroplasty in conjunction with a loop gastric bypass, which causes weight loss by both restriction and malabsorption. According to Rutledge's report, it is a safe and effective procedure with better reversibility.
Mini gastric bypass surgery is an effective treatment for sustained weight loss in morbid obese subjects. Also there is a reversion or cure of the metabolic syndrome in the great majority of the patients after surgery, as there is a marked reduction in the insulin resistance is found, and this phenomenon affects directly the pathophysiologic basis of the metabolic syndrome.
All obesity related co-morbidities decreased significantly after surgery. All hyperglycemia resolved within 6 months, and patients with diabetes were able to cease all medication.
Morbidly obese patients are already considered high risk because of their comorbidities. The surgical procedures for obesity are completely elective. Patients expect to do well have no complications and lose weight with no adverse sequelae from the procedure or the weight loss.
However there are multiple complications that are already established following mini gastric bypass, the most common are pulmonary complications.
Other complications include leaks, internal hernias, bleeding and nutritional deficiency. leakage is a fatal complication if not diagnosed and managed early, proper intervention at the proper time can save patient life, intervention include both conservative management and surgery either open or laparoscopic.
The field of bariatric surgery has become a very popular and competitive area of medicine, as the incidence of morbid obesity continues to rise and bariatric surgeons respond to the demand for effective treatments. While many doctors prefer to perform the bariatric procedures that have lasted through years of medical scrutiny, other doctors are developing alternatives. One such development is the mini-gastric bypass (MGB), a variation of gastric bypass surgery, which was developed in 1997 by Dr. Robert Rutledge. The mini-gastric bypass reverts back to the simpler loop reconstruction of earlier gastric bypass procedures, but with some improvements. The mini-gastric bypass surgery involves creating a long narrow gastric pouch and connecting new stomach to the side of the small intestine, bypassing 200 cm.
The laparoscopic mini-gastric bypass (LMGB), first reported by Rutledge, is a procedure which uses a divided vertical tube gastroplasty in conjunction with a loop gastric bypass, which causes weight loss by both restriction and malabsorption. According to Rutledge's report, it is a safe and effective procedure with better reversibility.
Mini gastric bypass surgery is an effective treatment for sustained weight loss in morbid obese subjects. Also there is a reversion or cure of the metabolic syndrome in the great majority of the patients after surgery, as there is a marked reduction in the insulin resistance is found, and this phenomenon affects directly the pathophysiologic basis of the metabolic syndrome.
All obesity related co-morbidities decreased significantly after surgery. All hyperglycemia resolved within 6 months, and patients with diabetes were able to cease all medication.
Morbidly obese patients are already considered high risk because of their comorbidities. The surgical procedures for obesity are completely elective. Patients expect to do well have no complications and lose weight with no adverse sequelae from the procedure or the weight loss.
However there are multiple complications that are already established following mini gastric bypass, the most common are pulmonary complications.
Other complications include leaks, internal hernias, bleeding and nutritional deficiency. leakage is a fatal complication if not diagnosed and managed early, proper intervention at the proper time can save patient life, intervention include both conservative management and surgery either open or laparoscopic.
Other data
| Title | Laparoscopic Mini Gastric Bypass Surgery For Morbid Obesity | Other Titles | تحويل مسار المعدة المصغرة بالمنظار لعلاج السمنة المفرطة | Authors | RamyFouad Hafez | Issue Date | 2014 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.